JOE TITTLE: Open Payments
NPI 1881620482 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,458 in 47 payments from 16 companies in 2025. Trend: 2023 $2,161 · 2024 $2,256 · 2025 $1,458
Food & beverage: $1,458
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $615 |
| Lilly USA, LLC | 6 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $112 |
| PFIZER INC. | 6 | $108 |
| Medtronic, Inc. | 1 | $82 |
| Novo Nordisk Inc | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| ABBVIE INC. | 3 | $62 |
| Radius Health, Inc. | 3 | $57 |
| Astellas Pharma US Inc | 2 | $40 |
Products named: AIRSUPRA, FARXIGA, Kerendia, SYNCHROMEDII, MOUNJARO, Tymlos, NURTEC ODT, Ozempic.
Industry payments across TX — which companies pay providers there.
